Ví dụ về việc sử dụng Invasive breast trong Tiếng anh và bản dịch của chúng sang Tiếng việt
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
Stage IB describes invasive breast cancer in which.
During that time, more than 3,000 women developed invasive breast cancer.
During this time, 1,536 invasive breast cancers were identified.
However, these cells can sometimes progress to invasive breast cancer.
Six factors may predict invasive breast cancer recurrence after DCIS diagnosis.
By January 2013, 1,457 women had developed invasive breast cancer.
There's 1.7million invasive breast cancers being diagnosed globally this year.
It accounts for about 8 out of 10 invasive breast cancers.
Craig- About one in eight women in the U.S. will develop invasive breast cancer in their lifetime, making it the most common cancer among American women after skin cancers, according to the American Cancer Society.
Other stages of breast cancer describe invasive breast cancer.
It is expected that around 266,120 new cases of invasive breast cancer will be diagnosed in the U.S. this year, and around 40,920 women will die from the disease.
Though, these cells can ultimately develop into invasive breast cancer.
Some women diagnosed with DCIS will go on to develop invasive breast cancer and some will die from the disease, but at present, there is no way to determine which women will do so.
However, these cells can eventually develop into invasive breast cancer.
It's estimated that about 1 in8 U.S. women will develop invasive breast cancer over the course of their lifetime, and according to the World Health Organization, there were 18.1 million new cases and 9.6 million deaths worldwide last year alone.
These are the main forms of invasive breast cancer.
About one in eight women in the U.S. will develop breast cancer during their lifetime, and the American Cancer Society(ACS)estimate that doctors will diagnose around 268,600 new cases of invasive breast cancer in 2019.
It is also used for reduction of risk and treatment of invasive breast cancer, and it also reduces breast density.
Overall, the team identified 517 women who died from breast cancer after DCIS diagnosis,despite never developing invasive breast cancer.
It is estimated that in2016 the United States has about 2,600 invasive breast cancers diagnosed in men, while in the UK it is 350 and Australia is 150.
The American Cancer Society estimates more than250,000 women will be diagnosed with invasive breast cancer in 2017[3].
Komen organization, in 2017,it's estimated that there will be 252,710 new cases of invasive breast cancer and 40,610 deaths from breast cancer among women in the U.S. These shocking and sad statistics make it even more critical for women to be properly educated on which lifestyle factors and habits may increase their risk for the disease.
American Cancer Society notes that almost two-thirds of the patients of invasive breast cancer are women of ages older than 55.
An updated comprehensive analysis of all SERM prevention trials showed that they are able to reduce the incidence of breast cancer in high- and average-risk women,an effect that is sustained by a reduction in ER-positive invasive breast cancer.
In a large study including 1,893 women from the Life After Cancer EpidemiologyStudy who had been diagnosed with early-stage invasive breast cancer, higher amounts of high-fat dairy product consumption were associated with higher mortality rates.
These cells usually do not cause any symptoms and cannot spread to the lymph nodes oraround the body as invasive breast cancer cells can.
In an American Cancer Society study, women who spent 6 hours or more each a day sitting when notworking had a 10% greater risk for invasive breast cancer compared with women who sat less than 3 hours a day, and an increased risk for other cancer types as well.
There's a 1 in 8 chance a woman in the United States will develop breast cancer sometime in her life andthe American Cancer Society estimated that about 268,600 new cases of invasive breast cancer will be diagnosed in women in 2019.
A report in September 2009 from Health and Human Services' Agency for Healthcare Research and Quality suggests that tamoxifen, raloxifene,and tibolone used to treat breast cancer significantly reduce invasive breast cancer in midlife and older women, but also increase the risk of adverse side effects.